Correction: Effectiveness of ixekizumab in 709 real-world patients with axial spondyloarthritis and psoriatic arthritis: a nationwide cohort study. BMJ Publishing Group.
Chicago Style (17th ed.) CitationCorrection: Effectiveness of Ixekizumab in 709 Real-world Patients with Axial Spondyloarthritis and Psoriatic Arthritis: A Nationwide Cohort Study. BMJ Publishing Group.
MLA (9th ed.) CitationCorrection: Effectiveness of Ixekizumab in 709 Real-world Patients with Axial Spondyloarthritis and Psoriatic Arthritis: A Nationwide Cohort Study. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.